Literature DB >> 31775055

Decreased K13 Abundance Reduces Hemoglobin Catabolism and Proteotoxic Stress, Underpinning Artemisinin Resistance.

Tuo Yang1, Lee M Yeoh2, Madel V Tutor1, Matthew W Dixon1, Paul J McMillan3, Stanley C Xie1, Jessica L Bridgford1, David L Gillett1, Michael F Duffy2, Stuart A Ralph1, Malcolm J McConville1, Leann Tilley4, Simon A Cobbold5.   

Abstract

Increased tolerance of Plasmodium falciparum to front-line artemisinin antimalarials (ARTs) is associated with mutations in Kelch13 (K13), although the precise role of K13 remains unclear. Here, we show that K13 mutations result in decreased expression of this protein, while mislocalization of K13 mimics resistance-conferring mutations, pinpointing partial loss of function of K13 as the relevant molecular event. K13-GFP is associated with ∼170 nm diameter doughnut-shaped structures at the parasite periphery, consistent with the location and dimensions of cytostomes. Moreover, the hemoglobin-peptide profile of ring-stage parasites is reduced when K13 is mislocalized. We developed a pulse-SILAC approach to quantify protein turnover and observe less disruption to protein turnover following ART exposure when K13 is mislocalized. Our findings suggest that K13 regulates digestive vacuole biogenesis and the uptake/degradation of hemoglobin and that ART resistance is mediated by a decrease in heme-dependent drug activation, less proteotoxicity, and increased survival of parasite ring stages.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SILAC; antimalarial; artemisinin; cytostome; kelch13; malaria; protein turnover; proteomics

Mesh:

Substances:

Year:  2019        PMID: 31775055     DOI: 10.1016/j.celrep.2019.10.095

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  36 in total

Review 1.  Malaria parasite plasmepsins: More than just plain old degradative pepsins.

Authors:  Armiyaw S Nasamu; Alexander J Polino; Eva S Istvan; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2020-05-04       Impact factor: 5.157

2.  Artemisinin-Based Drugs Target the Plasmodium falciparum Heme Detoxification Pathway.

Authors:  Kaleab A Ribbiso; Laura E Heller; Abigail Taye; Erin Julian; Andreas V Willems; Paul D Roepe
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

3.  A new mass spectral library for high-coverage and reproducible analysis of the Plasmodium falciparum-infected red blood cell proteome.

Authors:  Ghizal Siddiqui; Amanda De Paoli; Christopher A MacRaild; Anna E Sexton; Coralie Boulet; Anup D Shah; Mitchell B Batty; Ralf B Schittenhelm; Teresa G Carvalho; Darren J Creek
Journal:  Gigascience       Date:  2022-03-07       Impact factor: 6.524

Review 4.  Recent metabolomic developments for antimalarial drug discovery.

Authors:  Lúcia Mamede; Fanta Fall; Matthieu Schoumacher; Allison Ledoux; Pascal De Tullio; Joëlle Quetin-Leclercq; Michel Frédérich
Journal:  Parasitol Res       Date:  2022-10-04       Impact factor: 2.383

5.  Dimeric Artesunate Glycerophosphocholine Conjugate Nano-Assemblies as Slow-Release Antimalarials to Overcome Kelch 13 Mutant Artemisinin Resistance.

Authors:  Xinsong Li; Leann Tilley; Yawei Du; Carlo Giannangelo; Wei He; Gerald J Shami; Wenya Zhou; Tuo Yang; Darren J Creek; Con Dogovski
Journal:  Antimicrob Agents Chemother       Date:  2022-04-13       Impact factor: 5.938

6.  A Proteasome Mutation Sensitizes P. falciparum Cam3.II K13C580Y Parasites to DHA and OZ439.

Authors:  Melissa R Rosenthal; Caroline L Ng
Journal:  ACS Infect Dis       Date:  2021-05-10       Impact factor: 5.578

7.  Autophagy Underlies the Proteostasis Mechanisms of Artemisinin Resistance in P. falciparum Malaria.

Authors:  Ananya Ray; Miti Mathur; Deepak Choubey; Krishanpal Karmodiya; Namita Surolia
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

Review 8.  Artemisinin susceptibility in the malaria parasite Plasmodium falciparum: propellers, adaptor proteins and the need for cellular healing.

Authors:  Colin J Sutherland; Ryan C Henrici; Katerina Artavanis-Tsakonas
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

9.  Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness.

Authors:  Barbara H Stokes; Satish K Dhingra; Kelly Rubiano; Sachel Mok; Judith Straimer; Nina F Gnädig; Ioanna Deni; Kyra A Schindler; Jade R Bath; Kurt E Ward; Josefine Striepen; Tomas Yeo; Leila S Ross; Eric Legrand; Frédéric Ariey; Clark H Cunningham; Issa M Souleymane; Adama Gansané; Romaric Nzoumbou-Boko; Claudette Ndayikunda; Abdunoor M Kabanywanyi; Aline Uwimana; Samuel J Smith; Olimatou Kolley; Mathieu Ndounga; Marian Warsame; Rithea Leang; François Nosten; Timothy Jc Anderson; Philip J Rosenthal; Didier Ménard; David A Fidock
Journal:  Elife       Date:  2021-07-19       Impact factor: 8.140

10.  Isolation of Mutants With Reduced Susceptibility to Piperaquine From a Mutator of the Rodent Malaria Parasite Plasmodium berghei.

Authors:  Mie Ikeda; Makoto Hirai; Shin-Ichiro Tachibana; Toshiyuki Mori; Toshihiro Mita
Journal:  Front Cell Infect Microbiol       Date:  2021-06-16       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.